Etomidate and Vascular resistance systemic decreased - a phase IV clinical study of FDA data

Summary:

Vascular resistance systemic decreased is reported only by a few people who take Etomidate.

The phase IV clinical study analyzes which people take Etomidate and have Vascular resistance systemic decreased. It is created by eHealthMe based on reports of 2,045 people who have side effects while taking Etomidate from the FDA, and is updated regularly.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On May, 22, 2022

2,045 people reported to have side effects when taking Etomidate.
Among them, 2 people (0.1%) have Vascular resistance systemic decreased.


What is Etomidate?

Etomidate has active ingredients of etomidate. eHealthMe is studying from 2,050 Etomidate users for its effectiveness, alternative drugs and more.

What is Vascular resistance systemic decreased?

Vascular resistance systemic decreased is found to be associated with 158 drugs and 46 conditions by eHealthMe.

Number of Etomidate and Vascular resistance systemic decreased reports submitted per year:

Could Etomidate cause Vascular resistance systemic decreased?

Age of people who have Vascular resistance systemic decreased when taking Etomidate *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Common drugs people take besides Etomidate *:

  1. Cefuroxime: 2 people, 100.00%
  2. Ramipril: 1 person, 50.00%
  3. Atropine: 1 person, 50.00%

Common side effects people have besides Vascular resistance systemic decreased *:

  1. Hypotension (abnormally low blood pressure): 2 people, 100.00%
  2. Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin): 2 people, 100.00%
  3. Rashes (redness): 2 people, 100.00%
  4. Angioedema (rapid swelling of the dermis): 2 people, 100.00%
  5. Multi-Organ Failure (multisystem organ failure): 2 people, 100.00%
  6. Anuria (failure of the kidneys to produce urine): 2 people, 100.00%
  7. Lactic Acidosis (low ph in body tissues): 2 people, 100.00%
  8. Hypovolaemia (a decreased volume of circulating blood in the body): 2 people, 100.00%
  9. Capillary Leak Syndrome (capillary leaks plasma): 2 people, 100.00%
  10. Fibrinolysis Increased: 2 people, 100.00%

Common conditions people have *:

  1. High Blood Pressure: 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Etomidate and have Vascular resistance systemic decreased?

Check whether Vascular resistance systemic decreased is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of Etomidate:

Vascular resistance systemic decreased treatments and more:

COVID vaccines that are related to Vascular resistance systemic decreased:

How severe was Vascular resistance systemic decreased and when was it recovered:

Expand to all the drugs that have ingredients of etomidate:

All the drugs that are associated with Vascular resistance systemic decreased:

All the conditions that are associated with Vascular resistance systemic decreased:

How the study uses the data?

The study uses data from the FDA. It is based on etomidate (the active ingredients of Etomidate) and Etomidate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: